The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering The Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice for the Pharmaceutical Industry at arm’s length from the ABPI.
The Code covers:
- the promotion of medicines for prescribing to health professionals
- the provision of information to the public about prescription only medicines in the UK.
PMCPA e-alerts
Sign up to receive the latest news and updates from the PMCPA. Find out how here...
Latest News
ProStrakan Group plc, Cephalon UK Limited and GlaxoSmithKline Consumer Healthcare have each breached the ABPI Code of Practice for the Pharmaceutical Industry. To highlight these breaches, all are the subject of advertisements in the medical, pharmaceutical and nursing press.
ProStrakan – Case AUTH/2235/5/09
For making claims about Abstral that were misleading and did not comply with a previous undertaking, ProStrakan was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon and reducing confidence ...
Latest Advice
The ABPI has issued guidance notes on joint working between pharmaceutical companies and the NHS and others for the benefit of patients. The ABPI g...
As companies are aware, the revised Pharmaceutical Price Regulation Scheme requires prices of medicines to be reduced with effect from 1 February 2...
It has been drawn to the PMCPA’s attention that some companies believe that there is a three month grace period in which to update prescribing in...
